Russia to reveal its previously endorsed COVID-19 drug one week from now Kumar Jeetendra | June 2, 2020 Russia will begin giving its first medication affirmed to treat COVID-19 to patients one week from now, its state money related benefactor told Reuters, a move it expectations will ease strains on the wellbeing framework and speed an arrival to typical monetary life. Russian clinics can start giving the antiviral medication, which is enlisted under …
Russia confident of propelling coronavirus immunization one month from now Kumar Jeetendra | July 16, 2020 Russia plans to make 30 million doses of an experimental COVID-19 vaccine domestically this year, with the possibility to produce a further 170 million doses abroad, the head of the nation’s autonomous wealth fund said. The first human trial of the vaccine, a month-long evaluation on 38 people, stopped this past week. Researchers concluded that …
Russia to enroll world’s first COVID-19 immunization on August 12 Kumar Jeetendra | August 10, 2020 The Russian COVID-19 vaccine candidate, being jointly developed by the Gamaleya Research Institute along with also the country’s Defence Ministry, is place to get registered on August 12, reports suggest. This would be the primary vaccine candidate against the novel coronavirus to become registered. News reports quoted Russia’s Deputy Health Minister Oleg Gridnev as confirming …
Russia finishes early preliminaries of second potential COVID-19 immunization: Report Kumar Jeetendra | September 8, 2020 Siberia’s Vector virology institute on September 8 finished early-stage human trials, called Phase II, of a second possible Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying. Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August after finishing early-stage human trials. “Today… …
Russia finishes clinical preliminaries of second potential COVID-19 immunization Kumar Jeetendra | September 30, 2020 Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency mentioned Russian customer safety watchdog Rospotrebnadzor as saying on Wednesday The institute completed early-stage human trials, known as Phase II, earlier this month.
Russia prepared to trial combined AstraZeneca, Sputnik V antibody in Ukraine Kumar Jeetendra | January 3, 2021 Russia is ready to run clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDIF) said on Saturday. Russia’s autonomous RDIF, which is marketing the Sputnik V vaccine overseas, announced in December trials to test …
